Evidence map›Paper›PMID 29548293›Full record

ArticleBMC complementary and alternative medicine2018

Taraxacum officinale and Urtica dioica extracts inhibit dengue virus serotype 2 replication in vitro.

María R Flores-Ocelotl, Nora H Rosas-Murrieta, Diego A Moreno, Verónica Vallejo-Ruiz, Julio Reyes-Leyva, Fabiola Domínguez, Gerardo Santos-López

Abstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Bioactive Compounds from Vegetal Organs ofInternational journal of molecular sciences · 2025
    Review
  7. Anti-DENV-2 Activity of Ethanolic Extracts fromPlants (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Papaya Leaf Extracts as Potential Dengue Treatment: An In-Silico Study.International journal of molecular sciences · 2022
    Article
  10. Article
  11. PeerJ · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Inhibitory Effects ofAntioxidants (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

María R Flores-OcelotlLaboratorio de Biología Molecular y Virología, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Km 4.5 Carr Federal Atlixco-Metepec, 74360, Metepec, Puebla, México.
Nora H Rosas-MurrietaLaboratorio de Bioquímica, Centro de Química, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Avenida San Claudio s/n, Puebla, 72570, México.
Diego A MorenoDepartment of Food Science and Technology, Phytochemistry and Healthy Foods Lab, CEBAS-CSIC, Campus Universitario de Espinardo 25, E-30100, Murcia, Spain.
Verónica Vallejo-RuizLaboratorio de Biología Molecular y Virología, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Km 4.5 Carr Federal Atlixco-Metepec, 74360, Metepec, Puebla, México.
Julio Reyes-LeyvaLaboratorio de Biología Molecular y Virología, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Km 4.5 Carr Federal Atlixco-Metepec, 74360, Metepec, Puebla, México.
Fabiola DomínguezLaboratorio de Biotecnología de Productos Naturales, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Km 4.5 Carretera Federal Atlixco-Metepec, CP 74360, Metepec, Puebla, México. irmafabiola@yahoo.com.
Gerardo Santos-LópezLaboratorio de Biología Molecular y Virología, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Km 4.5 Carr Federal Atlixco-Metepec, 74360, Metepec, Puebla, México. gerardo.santos.lopez@gmail.com.ORCID http://orcid.org/0000-0002-3793-3117

Funding

Consejo Nacional de Ciencia y Tecnología SALUD-2012-01-181249, FIS/IMSS/PROT/1084Instituto Mexicano del Seguro Social CTFIS/10RD/12/2011Secretaría de Educación Pública Redes Temáticas-SEP 2012
6 · The paper itself

Abstract

backgroundUrtica dioica, Taraxacum officinale, Calea integrifolia and Caesalpinia pulcherrima are widely used all over the world for treatment of different illnesses. In Mexico, these plants are traditionally used to alleviate or counteract rheumatism and inflammatory muscle diseases. In the present study we evaluated the activity of aqueous and methanolic extracts of these four plants, on the replication of dengue virus serotype 2 (DENV2).

methodsExtraction process was carried out in a Soxtherm® system at 60, 85 and 120 °C; a chemical fractionation in silica gel chromatography was performed and compounds present in the active fractions were identified by HPLC-DAD-ESI/MSn. The cytotoxic concentration and the inhibitory effect of extracts or fractions on the DENV2 replication were analyzed in the BHK-21 cell line (plaque forming assay). The half maximal inhibitory concentration (IC

resultsThe methanolic extracts at 60 °C of T. officinale and U. dioica showed the higher inhibitory effects on DENV2 replication. After the chemical fractionation, the higher activity fraction was found for U. dioica and T. officinale, presenting IC

conclusionsTwo fractions from U. dioica and T. officinale methanolic extracts with anti-dengue activity were found. The compounds present in both fractions were identified, several recognized molecules have demonstrated activity against other viral species. Subsequent biological analysis of the molecules, alone or in combination, contained in the extracts will be carried out to develop therapeutics against DENV2.

Indexed as

Antiviral AgentsChromatography, High Pressure LiquidDengueDengue VirusHumansMass SpectrometryPlant ExtractsTaraxacumUrtica dioicaVirus ReplicationAntiviral AgentsPlant ExtractsAntiviralCaesalpinia pulcherrimaCalea integrifoliaDengue virusTaraxacum officinaleUrtica dioica

Identifiers

PMID29548293
PMCPMC5857124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.